CTIS2023-504280-16-00进行中（未招募）1 期
A study to investigate JNJ-80202135 (nipocalimab) delivered subcutaneously via prefilled syringe autoinjector and via normal syringe
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
2 期
A trial to investigate the effects of multiple doses of JNJ-67484703 in patients with rheumatoid arthritis, ulcerative colitis and Sjögren’s syndromeRheumatoid arthritis, ulcerative colitis and Sjögren’s syndromeISRCTN31164692niversity of Birmingham45
尚未招募
2 期
Ayurvedic Management of Sarvasara Pittaja Mukhpaka - StomatitisCTRI/2024/07/070265Institute for Ayurved Studies and Research
进行中（未招募）
不适用
A Randomized Study of the JAK Inhibitor INCB018424 Tablets Compared to Best Available Therapy in Subjects with Primary Myelofibrosis (PMF), Post-Polycythemia Vera-Myelofibrosis (PPV-MF) or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) - COMFORT IIMedDRA version: 12.0Level: LLTClassification code 10028537Term: MyelofibrosisMyelofibrosisEUCTR2009-009858-24-ITIncyte Corporation150
已完成
1 期
A Study to Investigate How JNJ-38518168 May Affect the Plasma Levels of Methotrexate in Rheumatoid Arthritis ParticipantsRheumatoid ArthritisNCT01450982Johnson & Johnson Pharmaceutical Research & Development, L.L.C.20
已完成
1 期
Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-55375515 in Healthy ParticipantsHealthyNCT02623491Janssen Research & Development, LLC175